How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Infectious Disease Archives

Health Equity is Essential to Overcoming Antimicrobial Resistance

Novavax Seeks Full FDA Approval for COVID-19 Vaccine

Early Intervention with Tenofovir Alafenamide Reduces Risk of Adverse Effects in Hepatitis B Patients

New Meta-Analysis Highlights Most Effective Treatments for Clostridioides difficile Infection

COVID-19 Accelerates Progression of Atherosclerotic Plaque, Increases Risk for Cardiovascular Events

Novavax’s Updated COVID-19 Vaccine Demonstrates Enhanced Immune Response in Recent Study

Harnessing the Power of AI in the Fight Against Antimicrobial Resistance

Azole Fungicides in Agriculture Linked to Rising Resistance in Aspergillus fumigatus

Carbapenem Resistant Enterobacterales Poses a Significant Threat

Invivyd Tracks SARS-CoV-2 Evolution, Prepares for Future Variants

Schedule an Appointment

Quick Links

Patient Forms

Contact Us